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Abstract.  Glycosylphosphatidylinositol (GPI)- 
anchored membrane proteins are synthesized by the 
posttranslational attachment of a preformed glycolipid 
to newly made glycoproteins, a-Agglutinin is a GPI- 
anchored glycoprotein that gets expressed at the cell 
surface of MA Tc~ cells after induction with type a mat- 
ing factor. Mutants affecting the biosynthesis of GPI 
anchors were obtained by selecting for the absence of 
eL-agglutinin from the cell wall after induction with 
a-factor at 37°C. 10 recessive mutants were grouped 
into 6 complementation classes, gpi4 to gpi9. Mutants 
are considered to be deficient in the biosynthesis of 
GPI anchors, since each mutant accumulates an abnor- 
mal, incomplete GPI glycolipid containing either zero, 
two, or four mannoses. One mutant accumulates a com- 
plete precursor glycolipid, suggesting that it might be 
deficient in the transfer of complete precursor lipids to 
proteins. When labeled with [2-3H]inositol, mutants 
accumulate reduced amounts of radiolabeled GPI- 
anchored proteins, and the export of the GPI-anchored 
Gaslp out of the ER is severely delayed in several mu- 
tant strains. On the other hand, invertase and acid 
phosphatase are secreted by all but one mutant. All 
mutants show an increased sensitivity to calcofluor 
white and hygromycin B. This suggests that GPI- 
anchored proteins are required for the integrity of the 
yeast cell wall. 
M 
ANY glycoproteins of lower and higher eukaryotes 
are attached to the plasma membrane by means 
of a glycosylphosphatidylinositol (GPI)  1 anchor 
covalently linked to their carboxy terminus (15, 41). These 
anchors have the conserved core structure protein-CO-NH- 
(CH2)2-PO4-6Mancd-2Man~l-6Man~l-4GlcNH2-myo-ino- 
sitol-PO4-1ipid.  Anchors  are synthesized by stepwise  addi- 
tion of sugars and phosphoethanolamine to phosphatidyl- 
inositol (PI) to form the complete precursor (CP) glycolipid. 
The transfer of CP's onto proteins is effected by a yet un- 
identified enzyme complex that recognizes a GPI signal se- 
quence in the COOH-terminal 30--40 amino acids of GPI 
proteins. This enzyme complex cleaves off most of the GPI 
signal sequence and replaces it with the preassembled CP. 
Although  all biosynthetic reactions required  for GPI an- 
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chor biosynthesis have been reproduced in microsomal in 
vitro systems and are quite well understood (11, 13, 24, 25, 
37-40, 42, 43, 45), the identification and study of individual 
enzymes are still far from complete. Four genes required 
for GPI biosynthesis have been cloned by complementa- 
tion of mammalian somatic cell mutants deficient in the bio- 
synthesis of CP's (29-31, 46). These mutant cell lines were 
isolated by selecting for the loss of surface expression of 
GPI-anchored proteins, and show normal growth in tissue 
culture (28).  Of the four genes isolated by complementa- 
tion cloning, two are required for the addition of GlcNAc 
to PI (30, 46),  one for the addition  of the third,  i.e., the 
cd,2-1inked  mannose  (31),  and  one  for  the  addition  of 
phosphoethanolamine (29). In contrast to mammalian cell 
lines, GPI anchoring seems to be essential for yeast cells 
(33). Nevertheless, several conditional Saccharomyces cer- 
evisiae  mutants have been obtained in a screen for the ab- 
sence of [2-3H]inositol incorporation into proteins at 37°C 
(33,  56).  Mutants  belonging  to  three  complementation 
classes were deficient in the addition of GlcNAc to PI, and 
one other mutant did not add mannose to the GlcN-PI in- 
termediate. To obtain additional yeast mutants, we tried to 
develop a selection for GPI biosynthesis mutants in yeast. 
S.  cerevisiae  contains  numerous GPI proteins, some of 
which  are  very highly  glycosylated,  but  the  function  of 
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tracellular transport of two GPI proteins,  namely Gaslp 
and a-agglutinin, have been studied in some detail (17, 36, 
58, 74). Proteins receive their anchor in the ER (10), and 
are supposed to be transported to the Golgi apparatus by 
vesicular traffic, since  this  transport is controlled  by the 
same genes as the transport of soluble secretory proteins 
(7, 14, 59, 67).  Additionally, ER to Golgi apparatus trans- 
port of Gaslp has been shown to depend on ongoing sphin- 
golipid biosynthesis (26).  Whereas  Gaslp, as well as an- 
other GPI protein, cAMP-binding protein, are destined to 
stay at the plasma membrane (17, 48, 49, 54, 58), et-aggluti- 
nin  loses  the  inositolphospholipid  moiety  after  having 
reached the plasma membrane, and appears at the outer 
surface of the cell wall (36). The mature ct-agglutinin be- 
comes covalently linked  to the  13-glucans of the cell wall 
(35, 47, 75).  tx-Agglutinin has been shown to depend criti- 
cally on its GPI anchor for integration into the cell wall, 
since removal of the COOH-terminal hydrophobic GPI sig- 
nal sequence resulted in the loss of cell-surface attachment, 
and allowed efficient secretion of the truncated ct-aggluti- 
nin (69, 80). On the other hand, introduction of mutations 
in the COOH-terminal GPI signal sequence of Gaslp ren- 
ders the addition of a  GPI in the ER impossible, and re- 
suits in the ER retention of the unprocessed GPI protein 
(53). It thus can be expected that mutants deficient in the 
biosynthesis of the GPI glycolipid or its transfer to proteins 
would  either  retain  the  unprocessed  a-agglutinin  in  the 
ER, or would secrete fragments thereof, and would there- 
fore be deficient in the expression of a-agglutinin at the 
cell surface.  Here we  describe  the  results  of a  selection 
procedure based on this assumption. 
Materials and Methods 
Strains, Growth Conditions, and Materials 
S. cerevisiae strains were W303-1B (MATa ade2-1 canl-lO0 ura3-1 leu2-3, 
112 trpl-1 his3-11,15) and W303-1A (MATa ade2-1 canl-lO0 ura3-1 leu2-3, 
112 trpl-1  his3-11, 15), X2180-1A  (MATa), HMSF176 (MATa secl8-1), 
C4  (MATa leu2-3, 112 ura3-52 pmi40)  and RH932  (MATa end2-1 leu2 
ura3 bar1-1). Cells  were kept on yeast extract/peptone/dextrose (YPD) 
plates  (9),  and were cultured  in salt/dextrose (SD) medium containing 
salts, vitamins (but no myo-inositol  [Ins]), trace elements, and 2% glucose 
as a carbon source; SDC medium is the same, but in addition contains 1% 
casein hydrolysate. SDUA and SDCUA are SD and SDC media supple- 
mented with uracil and adenine, each at 40 txg/ml. The OD of dilute cell 
suspensions was measured in a 1-cm cuvette at 600 nm; 10D600  U of cells 
corresponds to 1-2.5  x  107 cells, depending on the strain. Reagents were 
obtained  from  the  following  sources:  anti-rabbit-IgG/alkaline  phos- 
phatase conjugate  (A2556)  from Sigma Chemical Co.  (St.  Louis, MO); 
Amberlite XAD-2 resin from Serva Fine Biochemicals (Heidelberg, Ger- 
many); Dynabeads M-280 coupled to sheep anti-rabbit-IgG from Milan 
Analytical AG (La Roche, Switzerland);  EN3HANCE from NEN (Hert- 
fordshire, UK); 0.2-mm-thick  silica gel 60 plates (20 x  20 cm) from Merck 
(Darmstadt, Germany); mixed bed ion exchange resin (AG-501-X8;  Bio- 
Rad Laboratories, Richmond, CA) ammonia in methanol (7 M; Janssen 
Chimica,  Beerse, Belgium); phosphatidylinositol-specific phospholipase C 
(PI-PLC)  from Boehringer Mannheim GmbH (Mannheim,  Germany). 
GPI-phospholipase D (PLD) purified 1,000-fold from bovine serum was a 
kind gift of Dr. U. Brodbeck, University of Bern, Bern, Switzerland. 
a-Factor was isolated by incubation of cells with Amberlite XAD-2 resin, 
and quantitated as described  (73). A polyclonal antiserum was raised against 
a-agglutinin in a rabbit by repeated s.c. and i.v. injection  as described (79). 
Isolation of GPI-deficient Mutants 
Mutants were obtained using the scheme depicted in Fig. 2. Ethyl meth- 
anesulfonate mutagenesis was performed as described (34), and cells were 
allowed to recover by an overnight incubation at 24°C in SDCUA, buff- 
ered to pH 5.0 with 0.05 M phosphate. Before immunoselection, 3 ml of 
Dynabeads M-280 suspension (6-7 ×  108 beads per ml) were prewashed, 
once with 25 ml PBS, twice with 25 ml PBS containing 5% FCS, and once 
with 25 ml PBS containing 1% FCS (PBSF), and finally resuspended in 15 
ml of PBSF.  108 mutagenized cells  were resuspended in 10 ml SDCUA 
buffered with 0.05 M phosphate to pH 5; cells were preincubated for 15 
min at 37°C, and then stimulated with a-factor (20 U/ml, final concentra- 
tion) for 90 min at 37°C. The cells were then washed with 25 ml PBSF at 
37°C, resuspended in 4.5 ml PBSF, and 0.5 ml anti-a-agglutinin rabbit an- 
tiserum was added. Cells were incubated 90 min at 37°C on a slowly rotat- 
ing wheel.  Cells were then washed five times with 20 ml of PBSF, and re- 
suspended in 10 ml PBSF. For the first round of immunoselection, 5 ml of 
prewashed Dynabeads  (coated  with  sheep  anti-rabbit-IgG antibodies) 
was added to the cells, and was incubated with the cells for 90 min at 24°C 
on a wheel. The tube was then placed for 5 min against the magnet, and 
the medium with the unbound ceils was collected  in a recipient vessel. At 
this stage,  the magnetic beads were washed five times, by each time re- 
moving the tube from the magnet, resuspending beads in fresh PBSF (15 
ml), placing the tube next to the magnet for 5 min, and collecting  the free 
cells into the recipient vessel.  These washings were necessary to recover 
the cells that display  a normal, constitutive expression of tx-agglutinin  at 
24°C.  Cells  pooled in the recipient vessel were then centrifuged,  resus- 
pended, and subjected to a second and a third round of immunoselection 
by adding fresh Dynabeads and incubating another 90 min for each round. 
Finally,  cells  that  were  not  firmly  bound  to  Dynabeads  during  three 
rounds of selection were resuspended in PBSF, plated on YPD plates, and 
incubated  for 3-4  d  at  24°C. YPD  plates were  replicated,  and  replica 
plates were incubated for 2 d at 37°C to allow for selection of clones that 
are temperature sensitive  (ts) for growth, ts mutants were tested for acid 
phosphatase secretion by replica plating clones grown at 24°C onto phos- 
phate-free SDCUA plates, and incubating the replicas at 37°C for 1-2 d. 
Replica  plates were then processed for the detection  of secreted phos- 
phatase as described  (21).  Mutants able  to secrete acid  phosphatase at 
37°C were picked to be further screened for GPI defects. 
Radiolabeling with [2-3H]myo-inositol 
For further analysis,  mutant strains were labeled with [2-3H]myo-inositol 
([2-3H]Ins).  Cells were grown in SDCUA medium, 2.50D600  U of expo- 
nentially growing cells  were resuspended in 0.25 ml SDCUA, preincu- 
bated 20 min at 37°C, and 5 ~Ci [2-3H]Ins were added. Cells were then in- 
cubated for 20 min at 37°C, and diluted with 1 ml of prewarmed SDCUA, 
and further incubated for 70 min at 37°C. At the end, cells were washed 
with water. Lipids were extracted and desalted by butanol extraction as 
described (70). Lipid extracts were analyzed by ascending TLC using 0.2- 
mm-thick silica gel plates with the solvent system chloroform/methanol/ 
water (10:10:3). As standards, we used previously characterized [2-3H]Ins  - 
and [2-3H]mannose-labeled lipids from S. cerevisiae. (61, 70). Radioactiv- 
ity  was detected  by two-dimensional radioscanning (LB  2842; Berthold 
AG,  Regensdorf,  Switzerland)  or  else,  TLC  plates  were  sprayed with 
EN3HANCE and exposed to film (X-OMAT; Eastman Kodak Co., Roch- 
ester, NY) at -80°C. 
For protein analysis, Laemmli sample buffer (32) was added to labeled 
cells (25 izl/OD600), and cells were broken by vortexing with glass beads (3 x 
1 min). Samples were boiled 5 min at 95°C, centrifuged 10 min at 10,000 g 
to remove cell walls, and the supernatant was run on an SDS-PAGE gra- 
dient gel 7.5-15 % (32). Gels were treated with EN3HANCE and exposed 
to Kodak X-OMAT film at -80°C. 
Analysis of  Abnormal 
[2-3H]myo-inositol-labeled Lipids 
Purification of radiolabeled glycolipids  was achieved by preparative TLC 
in the same solvent system as above, radioactive  glycolipids  of interest 
were localized  by two-dimensional radioscanning, and were scraped and 
eluted with the solvent. Before further analysis,  an aliquot of purified gly- 
colipids was run on analytical  TLC to check for purity. 
Soluble head groups were obtained from purified glycolipids  through 
selective  removal of acyl groups attached to the Ins using methanolic NH  3 
followed by PI-PLC treatment in 20%  1-propanol (60).  Fatty acids  and 
lipids  were removed by butanol extraction. Head groups were subjected 
to hydrofluoric acid  (HF) dephosphorylation and then to N-acetylation, 
and were desalted using mixed-bed ion exchange resin AG-501-X8 (Bio- 
Rad Laboratories, Hercules, CA) (60). N-acetylated, water-soluble head 
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three consecutive runs in solvent A  (1-propanol/acetone/water 9:6:5, vol/ 
vol) and solvent B  (1-propanol/acetone/water 5:4:1,  vol/vol) used in the 
order A, B, A  as described (68). Previously described methods were used 
for mild base hydrolysis (18), jack bean c~-mannosidase (JBAM)  treat- 
ment (62), and GPI-PLD treatment (12) of lipid mixtures. Treated lipid 
mixtures were desalted by extraction with butanol before TLC. 
Measurement of lnvertase Secretion 
To measure periplasmic invertase in intact cells, the cells were grown to 
mid-logarithmic phase in SDCUA with the glucose content raised to 5% 
(SDsCUA) at 24°C with shaking. 10 OD600 U of cells were pelleted, resus- 
pended in 20 ml SDsCUA, and preincubated for 60 min at 37°C.  Cells 
were then pelleted, washed with water at 37°C, resuspended in 20 ml of 
SDCUA with the glucose content reduced to 0.05% (SDa05CUA), and in- 
cubated at 37°C. 200-t~1 aliquots were removed every 15 rain during 1 h. 
These aliquots were adjusted to 10 mM NAN3, 10 mM NaF, and 10 ~g/ml 
cycloheximide, and were kept on ice until they were washed three times 
with water and external invertase activity was measured (19).  The OD600 
of each aliquot was measured to allow calculation of the invertase activity 
per OD600 U  of cells. 
Invertase Glycosylation 
Cells were grown to mid-logarithmic phase in SDsCUA at 24°C with shak- 
ing. 5-OD600 U  aliquots were resuspended in 10 ml SDsCUA, and incu- 
bated for 60 min at 24°C or 37°C, respectively. Cells were then washed 
with water at 24°C or 37°C, and resuspended in SD0.05CUA, and incubated 
for 60 min at 24°C or 37°C, respectively. Metabolism was then arrested by 
the addition of 10 mM NaN3, 10 mM NaF, and 10 ixg/ml cycloheximide, 
and extracts prepared for native gel electrophoresis and activity stain as 
described (2). 
Expression of a-agglutinin at the Cell Surface 
Cells were grown at 24°C to an OD600 of 1-2 in SDCUA, and buffered to 
pH 5.0.  Cells were resuspended in fresh SDCUA, pH 5, and 0.16-ml ali- 
quots (0.625 OD600/ml) of cells were either stimulated by a-factor (70 U/ml, 
final concentration), or control incubated for 3 h at 24°C or 37°C, respec- 
tively. Cells were then adjusted to 10 p~g/ml  cycloheximide, washed with 1 
ml buffer A  (10 mM Tris/HCl, pH 7.4, 100 mM MgCl2,  0.5% Tween 20, 
1% Triton X-100, 1% BSA, 5 % FCS, 10 }xg/ml cycloheximide). Cells were 
resuspended in 90 }xl buffer A, 10 ~1 rabbit anti-a-agglutinin antiserum 
was added, and incubation was continued for 90 min at 24°C. Cells were 
washed three times with 1 ml buffer A, and resuspended in 250 p.l buffer 
A. 1  Ixl anti-rabbit-IgG/alkaline phosphatase conjugate was added,  and 
cells were incubated for 45 min at 24°C. Cells were washed five times with 
buffer A, and alkaline-phosphatase activity was measured by incubation 
of cells with paranitrophenylphosphate during 10 rain as described (79). 
No activity was observed when the second antibody was omitted. 
Maturation of Gas  lp 
Maturation  of  Gaslp  was  followed  by  pulse-chase experiments using 
[3SS]methionine and [35S]cysteine  (Tran35/S label; ICN Biomedicals Inc., 
Irvine, CA), 1,027  Ci/mmol; 20 }xCi/OD600  of cells) followed by immuno- 
precipitation using a polyclonal rabbit anti-Gaslp antiserum (17) and pro- 
tein A-Sepharose as described (26). Western blotting was carried out with 
the same antiserum as described (26). 
Results 
Elaboration of Conditions for Immunoselection 
Mutants  with  defects  in  the  structural  genes  of  a-  and 
ct-agglutinins previously have been obtained by selecting 
for cells unable to form aggregates when mixed with cells 
of the  opposite mating type  (34,  65).  This approach was 
relatively  unsuccessful  for  obtaining  GPI-deficient  mu- 
tants,  possibly because this  procedure  selects for a  com- 
plete absence of agglutinins from the surface, so that cells 
exhibiting constitutive levels of agglutinins are eliminated, 
and only cells with defects in the agglutinin structural genes 
are selected. Thus, a less restrictive immunoselection pro- 
cedure  using a  highly specific polyclonal rabbit antibody 
against a-agglutinin was developed. As can be seen in Fig. 
1, W303-1B MA Tc~ cells, when induced with a-factor, were 
strongly stained by the antiserum, whereas only vacuolar 
staining was visible in noninduced cells. In preliminary ex- 
periments, W303-1B MATa cells were first induced with 
a-factor at 37°C, and were then incubated with anti-a-agglu- 
tinin antibodies. Absorption of these cells onto anti-IgG- 
coated magnetic beads was very efficient, even if cells had 
not been induced to express c~-agglutinin before. However, 
after extensive washing  of the  beads,  only 4%  of nonin- 
duced,  but  85%  of induced  cells  remained  fixed  to  the 
beads. Thus, through three consecutive rounds of adsorp- 
tion onto magnetic beads, followed each time by extensive 
washings, cells not expressing a-agglutinin at 37°C  could 
theoretically become enriched up to 300-fold. 
Immunoselection of GPI Mutants 
Mutants were selected using the procedure outlined in Fig. 
2.  Strain W303-1B  was mutagenized with ethyl methane- 
sulfonate,  and  surviving cells  (21%)  were  allowed to re- 
cover in  SDCUA through six mitotic cell cycles at 24°C. 
108 mutagenized cells were then induced to express a-agglu- 
tinin at 37°C,  and the cells expressing more than constitu- 
tive levels of a-agglutinin were removed using three consec- 
utive rounds of immunoselection. The negatively selected 
remaining cells (8.7%) were assumed to comprise all the 
dead cells generated by mutagenesis. On the basis of this 
assumption, we calculate that the immunoselection had re- 
moved 97%  of living cells.  The  negatively selected cells 
were then plated on YPD plates for growth at 24°C.  The 
Figure 1.  a-Agglutinin expression  by c~ cells as detected by anti- 
a-agglutinin  antibodies. W303-1B cells were incubated for 90 min 
in the absence (a) or presence (b) of a-factor, and decorated with 
polyclonal anti-ct-agglutinin  antibodies  followed by FITC-conju- 
gated goat anti-rabbit-IgG antibodies. Light microscopic pictures 
were taken using the same exposure times for a and b. 
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mutagenesis, recovery 
$ 
induction of c~-agglutinin with a mating factor at 37°C 
$ 
immunoselection using anti-c~-agglutinin antibodies 
$--~ discard adherent cells 
plate nonadherent cells (deficient in c~-agglutinin expression) 
$ 
screen for clones with ts phenotype for growth on agar (not growing at 
37°C) 
$ 
screen for ts clones that secrete acid phosphatase at 37°C 
4 
Screen for clones that do not incorporate [3Hlmyo-inositol  into proteins 
or that accumulate abnormal GPI lipids at 37°C 
Figure 2.  Protocol for selection of gpi mutants. 
plating  efficiency was only 10%,  suggesting that  a  major 
fraction  of the  selected  cells  indeed  were  dead  cells  left 
over from the mutagenesis.  Of the growing clones, those 
that did not grow at 37°C were selected (20%),  and these 
ts clones were further screened for acid phosphatase secre- 
tion at 37°C. 72%  of ts clones secreted  acid phosphatase 
normally,  and  these  clones  were  labeled  with  [2-3H]Ins. 
Lipid  extraction,  TLC,  and  fluorography  were  used  to 
screen for the presence of abnormal [2-3H]Ins-labeled lip- 
ids,  whereas  the  incorporation  of [2-3H]Ins into proteins 
was monitored by SDS-PAGE and fluorography.  10 mu- 
tant  isolates  accumulated  a  distinct,  abnormal  [2-3H]Ins  - 
labeled lipid, and one mutant (gpi9) accumulated one ma- 
jor and several minor abnormal species  (Fig. 3).  In all  11 
mutants,  the  amount  of [2-3H]lns-labeled  proteins  accu- 
mulated during a 90-min pulse was significantly reduced as 
compared with wild type. This reduction was observed in 
all mutants when cells were labeled  at 37°C, and in many 
mutants even after labeling at 24°C (Fig. 4).  On the other 
hand, all mutants incorporated [2-3H]Ins into phospholip- 
ids  as efficiently as wild-type cells  (50-80%  of added  ra- 
dioactivity). In none of 400 other isolates was the incorpo- 
ration  of [2-3H]Ins into  proteins  abolished.  Retesting  of 
the growth phenotype  showed that  several  of the  11  iso- 
lates that initially had scored as ts were in fact not temper- 
ature sensitive for growth (Table I). In most mutants, the 
accumulation  of the  abnormal  lipid  was  enhanced  when 
cells were labeled at 37°C, but in several mutants, the ab- 
normal lipid could also be observed after labeling at 24°C 
(Fig. 3, Table I). The  l l  mutant isolates were outcrossed 
three  times  to X2180,  and  all  tetrads  were  labeled  with 
[2-3H]Ins at 37°C. The accumulation of an abnormal lipid 
segregated 2:2 in all cases and the ts growth phenotype, if 
present,  cosegregated  with  the  abnormal  lipid  in  all  but 
one isolate (gpi7-1). Also, the accumulation of distinct ab- 
normal lipids behaved as a stable trait, and the same lipids 
as in the original isolate were consistently observed in seg- 
regants, gpi7-4 and gpi8 stem from a single mutant isolate 
containing two independent  GPI defects; during  crossing 
of this isolate, two different spore phenotypes accumulat- 
ing two different abnormal lipids were obtained.  The two 
phenotypes were unlinked, and consistently segregated 2:2 
through three further outcrosses. One mutant (isolate 839) 
could not be mated. For complementation analysis, all mu- 
tants  accumulating the same abnormal lipid were crossed 
with each other and also with the isolate that accumulates 
a range of different abnormal lipids (gpi9, Fig. 3). Diploids 
were checked for the accumulation of abnormal lipids and, 
if ts strains were crossed, for growth at 37°C. The five iso- 
lates that accumulated lipid c~ were also crossed with sec53, 
sec59, dpml, and prni40, a series of ts mutants with known 
defects  in  mannose  biosynthesis  or  mannose  utilization. 
These  mutants  also  accumulate  lipid  a.  All five isolates, 
and all four known mutants accumulating lipid et comple- 
mented each other, except for one of our isolates that did 
not  complement sec53. This  isolate  was  not  studied  fur- 
ther.  Our isolates  accumulating lipid  c~ were  classified  as 
Figure 3.  Accumulation of abnormal lipids in gpi mutants. Lipids from mutant cells labeled at 24°C or 37°C with [2-3H]Ins were run on 
TLC and revealed by fluorography for 6 d. The first lane on left represents an experiment where a threefold longer exposure had been 
performed allowing a better view of the minor CP of gpi9. As will be shown below, lipid  ct corresponds to GlcN-acyllns-P-lipid; 13 to 
Man2-GlcN-acyllns-P-lipid;  ~/to Man4-GlcN-acyllns-P-lipid.  O, origin. 
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Fragments of lipid ~/from gpi7 and of CP1/CP2  from gpi8 
comigrated  with  Man4-GlcNAc-Ins  (Fig.  5).  Thus,  HF 
fragments of the major abnormal lipid of gpi7 and gpi8 are 
identical, but  only the  lipid of gpi8 comigrates with CP's 
on TLC, whereas lipid -,/of gpi7 is less polar. It therefore is 
possible that the lipid of gpi7 lacks the polar phosphoetha- 
nolamine substituent characteristic of CP's. Lipid a  of gpi9 
produced  a  GlcNAc-Ins fragment,  but  this  mutant  con- 
tains  several  additional  lipids  the  most  polar  of  which 
comigrates with CP2 (Fig. 3). 
The three GPI biosynthesis intermediates of yeast char- 
acterized so far contained an acyl chain on the Ins, rendering 
them resistant to PI-PLC (9, 55, 70). The [2-3H]Ins-labeled 
lipid extracts of all mutants were treated with PI-PLC and 
analyzed by TLC/fluorography. All abnormal mutant lip- 
ids were resistant to PI-PLC, whereas PI was completely 
hydrolyzed as expected (data not shown).  Thus,  by their 
comigration with well-characterized GPI intermediates on 
TLC, by the comigration of their HF fragments with GPI- 
derived HF fragments, and by their resistance to PI-PLC, 
the  abnormal  [2-3H]Ins-labeled mutant  lipids behave  as 
biosynthetic intermediates  of the  GPI  pathway.  To  con- 
Figure 4.  Incorporation of [2-3H]Ins into proteins ofgpi mutants. 
3 ×  outcrossed mutant strains were grown to mid-log phase, and 
were labeled with [2-3H]Ins. Proteins were extracted, run in SDS- 
PAGE, and revealed by fluorography. Each lane contains the to- 
tal extract of 2.50D600 U of cells labeled with 5 IxCi  of [2-3H]Ins. 
It should be noted that mature GPI-anchored proteins are exten- 
sively and heterogenously glycosylated, which leads to crowding 
at the border of the lane and smearing out (33,  55).  In parallel, 
the four strains from individual tetrads of the third outcross (see 
below) of each mutant were labeled with [2-3H]Ins to determine 
the efficiency of incorporation of [2-3H]Ins  into mutant strains. 
Efficiency of incorporation was calculated by dividing the mean 
of cpm in the lipid extracts of the two mutants by the mean of 
cpm of the  two wild-type strains derived from  a  single tetrad. 
Given as percentage of wild type, mutants incorporated with effi- 
ciencies of 104%  (gpi4), 72%  (gpi5), 81%  (gpi6), 95%  (gpi7-1), 
123% (gpi7-2), 108% (gpiT-3), 120% (gpi7-4), 155% (gpi8), 124% 
(gpi9). 
gpi4, gpi5, gpi6, and gpi9. Four isolates accumulating lipid 
~/did not complement each other,  and were classified as 
gpi7.  Labeling of diploid strains also allowed to conclude 
that lipid accumulation in gpi4, gpi5, gpi6, gpi7, gpi8, and 
gpi9 is a recessive trait. 
Characterization  of Abnormal Lipids 
Structural analysis was performed on the abnormal lipids 
of mutants to see whether or not they represent biosynthetic 
intermediates  of  the  GPI  pathway.  For  this,  [2-3H]Ins  - 
labeled  abnormal  lipids  were  isolated  from  preparative 
TLC  plates,  and  were  fragmented  using  HF.  Under  the 
conditions  used,  HF  specifically  cleaves  phosphoester 
bonds,  and  generates  Man×-GlcN-Ins  (x  =  0,  1,  2,  3,  4) 
from  GPI  biosynthetic  intermediates.  N-acetylated  HF 
fragments of the abnormal lipid ct isolated from gpi4, gpi5, 
and  gpi6  comigrated  with  GlcNAc-Ins,  the  fragment  of 
Figure 5.  Thin layer chromatogram of HF fragments generated 
from mutant lipids. The major abnormal [2-3H]Ins-labeled lipid 
of each mutant was isolated by preparative TLC, HF fragments 
were prepared and compared with known standard oligosaccha- 
rides by TLC. The lipids analyzed were lipid a  (gpi4, gpi5, gpi6, 
gpi9), f~ (mutant 839), ~ (gpi7), and CP1/CP2 (gpiS), the positions 
of which can be seen in Fig. 3. M0-M4, Man0- to Man4-GlcNAc- 
Ins (70).  Mixtures of two of these standards and Ins were run in 
parallel on  the  same plate, and  the positions of the respective 
standards were highlighted on the borders. The presence of Ins in 
839 and gpi7 is probably due to unadverted hydrolysis by HF fa- 
vored by heat production during neutralization at the end of the 
HF treatment. 
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cal with CP1/CP2 (Fig. 3), we performed additional chemi- 
cal  or enzymatic treatments.  Thereby  the  abnormal  lipid 
of gpi8  was  compared  with  the  well-characterized  CP's 
contained  in  the  [2-3H]mannose-labeled  lipid  extract  of 
pmi40, a mutant which, at 37°C, incorporates high amounts 
of [2-3H]mannose  due to a  temperature-dependent  defect 
of mannose biosynthesis  (57, 70).  As reported  previously, 
all  lipid  moieties  of  CP1  and  CP2  are  removed  by  mild 
base  hydrolysis;  they  are  cleaved  by  GPI-PLD  and  only 
three of the four mannoses of the isolated head groups are 
protected  against  JBAM  (70).  As  shown  in  Fig.  6,  treat- 
ment of CP1 and CP2 with JBAM increases their mobility 
to the  extent  that  is  expected  for the removal  of a  single 
mannose  residue.  The  abnormal  lipid  of gpi8  shows  the 
same  behavior  as  the  authentic  CP2  from pmi40  in  all 
treatments.  We  thus  conclude  that  gpi8  accumulates  a 
complete  GPI precursor. To confirm that lipid -/of gpi7 is 
an  earlier  intermediate  of  GPI  biosynthesis,  the  double 
mutant gpi7-1 gpi8  was  constructed.  The  double  mutant 
only  accumulated  lipid  "y  (not  shown).  Thus, gpi7 is  epi- 
static to gpi8, a finding consistent with the idea that lipid ~/ 
is a precursor of CP2. 
Secretion of lnvertase Is Independent of the Surface 
Expression of ~-agglutinin  and Maturation of Gaslp 
While mutants deficient in the surface expression of a-agglu- 
tinin but able to secrete acid phosphatase had been selected, 
the phenotype of these mutants with regard to secretion of 
Table I. Summary Table 
Figure 6.  Characterization  of the abnormal lipid accumulating  in 
gpi8. Gpi8 was labeled with  [2-3H]Ins, pmi40 with  [2-3H]-man - 
nose  (70),  both labelings  at  37°C.  Desalted  lipid  extracts  were 
subjected to mild base hydrolysis,  GPI-PLD treatment, or JBAM 
treatment  as indicated  at  the  bottom  (+).  Control  incubations 
without the hydrolytic agent were done in parallel  (-).  Treated 
lipids  were desalted  and analyzed by TLC/fluorography. DPM, 
dolicholphosphomannose. 
soluble  proteins  and  surface  expression  of  o~-agglutinin 
had to be verified. Invertase was induced by glucose depri- 
vation both after a 10-min and a 1-h preincubation at 37°C. 
The latter time was chosen to demonstrate invertase secre- 
tion  in  the  time  window  during  which  o~-agglutinin  nor- 
mally  appears  at  the  cell  surface  (36).  As  can  be  seen  in 
Complementation  class  °C  gpi4-1  gpi5-1  gpi6-1  839  gpi7-1  gpi7-2  gpi7-3  gpi7-4  gpi8-1  gpi9-1  W303 
Growth  24  +++  +++  ++  ++  +++  +++  +++  +++  +++  +++  +++ 
Accumulation of abnormal lipid (Fig. 3) 
Growth on  1 mg/ml CFW (Table I) 
Secretion of invertase (Fig. 7) 
Induction of a-agglutinin on cell surface at 37°C  (Fig. 8) 
Accumulation of immature Gas 1 p 
(Fig. 9) 
Slowed export of Gaslp out of ER (Fig.  10) 
Hypersensitivity  to vanadate 
Sensitivity to hygromycin B 
(50  Ixg/ml) 
Growth on Ca ++  (50 mM) 
Status of N-glycans of invertase (Fig.  11) 
Incorporation of [2-3H]Ins into 
proteins 
Size of HF fragment of abnormal 
GPI  lipid 
37  --  +++  -  +  ++  +++  +++  ++  ++  --  +++ 
24  --  +  -  +  +  +  +  ++  -  -  -- 
37  +  +  +++  +++  +++  ++  +  +++  +  +÷+  -- 
24  ++  +++  +++  +  +++  +  +++  +++  ++  +++  +++ 
37  ......  ++  -  -  -  +++ 
37  +++  ++  +  +++  +++  +++  ++  +++  +++  +++  +++ 
37  -  +  --  --  +++  --  +  +++  +++  -  +++ 
24  n.t.*  n.t.  n.t.  n.t.  +  ++  ++  ++  +  n.t.  + 
37  +  +  ++  ++  ++  + 
37  n.t.  n.t.  n.t.  ++  +  n.t.  n.t.  n.t.  ++  n.t.  -- 
24  ........... 
37  n.t.  -  n.t.  +  -  -  -  +  +  n.t.  - 
24  .......  +  -  -  - 
37  n.t.  +  n.t.  ++  +  -  +  ++  -  n.t.  - 
24  no.*  no.  no.  no.  no.  no.  no.  no.  no.  no.  no. 
37  de. §  ~.11  no.  ~.  no.  no.  no.  no.  no.  no.  no. 
24  no.  no.  no.  no.  no.  no.  no.  no.  no.  no.  no. 
37  s.rJ  no.  s.r.  no.  no.  no.  no.  no.  no.  ~.  no. 
24  +  +++  ++  ++  +  +  +++  ++  +  ++  +++ 
37  (+)  ++  +  +  +  +  +  ++  +  +  +++ 
37  M0  M0  M0  M2  M4  M4  M4  M4  CP1  **M0  - 
CP2  CP2 
*, Not tested; 
*, normal; 
8, dependent; 
I, reduced; 
'1, slightly reduced; 
**, accumulates  several intermediates  from GlcN-acylPI up to CP2. 
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Figure 7.  Secretion  of invertase by gpi mutants. 3  ×  outcrossed 
strains were grown to mid-log phase at 24°C, were preincubated 
in SDsCUA for 1 h at 37°C, and invertase secretion was induced 
by transferring cells into SD0.0sCUA. After further incubation at 
37°C for 0, 15, 30, 45, or 60 min, periplasmic invertase activity was 
determined. 
Fig. 7, invertase was secreted into the periplasmic space by 
all  mutants  except for gpi6, which secreted  normally im- 
mediately upon shift to 37°C (not shown), but was unable 
to secrete invertase after 1 h of preincubation at 37°C. Inci- 
dentally, normal secretion of invertase also documents that 
a given mutant has no defects in transcription (4, 5), trans- 
lation,  and translocation of secretory proteins,  c~-Aggluti- 
nin expression was measured by an ELISA test, whereby 
the conditions and the duration of induction with a factor 
were the same as in the initial mutant selection procedure 
(Fig. 8). A  conceptual difficulty of this assay lies in the fact 
that  cx-agglutinin  expression  was  tested  after  three  out- 
crosses to X2180, a strain which has a relatively high, con- 
stitutive  level of expression,  and which induces a-aggluti- 
nin only 1.3-fold (79). Thus, the different mutants are not 
isogenic and cannot be compared among each other, but 
each mutant has to be considered independently.  In doing 
so, one can see that in all but three mutants, the induction 
of a-agglutinin expression on the cell surface at 37°C is sig- 
nificantly lower than at 24°C. Exceptions are gpi7-1, gpi7-4, 
and gpi8. These mutants can be assumed to have filtered 
through the original immunoselection, because gpi7-4 and 
gpi8 were present in the same clone, and gpi7-1 was com- 
bined with another, unrelated mutation causing a ts growth 
phenotype  (see  above).  Thus,  it  is  conceivable  that  the 
combination of mutations in these original isolates resulted 
in a low expression of o~-agglutinin at 37°C. 
To test further whether  GPI anchor addition  was com- 
promised,  the  biosynthesis  of  Gaslp  was  studied  in  the 
mutants  blocked  at  later  stages  of GPI biosynthesis.  On 
SDS-PAGE, the ER form of Gaslp has an apparent mo- 
lecular mass of 105 kD; upon entry into the Golgi appara- 
tus, the elongation of N- and O-glycans increases the size 
to 125 kD (17, 74). Gaslp is retained in the ER as long as 
the  GPI anchor is not attached  to it  (26, 53). Protein  ex- 
tracts from mutants precultured  at 24  ° or 37°C were ana- 
lyzed by Western  blotting  with  anti-Gaslp  antibody.  As 
can be seen in Fig. 9, as compared to wild-type cells, the 
relative  amount of the ER precursor  form of Gaslp  was 
increased  in  several  mutants  already  when  they  were 
grown  at  24°C,  and  this  tendency was  enhanced  in  ceils 
grown  at  37°C.  This  suggested  that  the  maturation  of 
Gaslp was delayed in these mutants. To further document 
this idea, the transit of Gaslp from the ER to the Golgi ap- 
paratus was studied by pulse-chase experiments in gpiT-1, 
gpi8,  and  839,  three  strains  which secrete  invertase  nor- 
Figure 8.  Surface  expression  of  a-agglutinin  by gpi  mutants. 
a-Agglutinin was induced with a-factor at 24°C or 37°C during 3 h, 
and the amount of a-agglutinin at the surface was then quanti- 
tated by ELISA. Results are given as the absorbance at 405 nm 
produced by reagents bound to 0.10D600 U of cells in 10 min at 
37°C.  3  ×  outcrossed  mutants  were  analyzed.  D,  24°C  nonin- 
duced;  II, 24°C  induced;  [], 37°C  non induced;  [],  37°C  in- 
duced. 
mally  (Fig.  7).  As  shown  in  Fig.  10,  maturation  of the 
pulse-labeled  105-kD ER form of Gaslp into the mature 
125-kD form during chase at 37°C was severely delayed in 
gpi8 and 839, and somewhat delayed in gpiT-1, but eventu- 
ally still occurred. The delay can account for the accumula- 
tion  of  immature  Gaslp  observed  by  Western  blotting 
(Fig.  9);  the  fact that  maturation  of Gaslp  is  eventually 
still possible  is in keeping with  the fact that these  strains 
still can grow at 37°C. 
N-Glycosylation of Most gpi Mutants Is Normal 
Mutants deficient in the biosynthesis of the dolichol-linked 
oligosaccharide precursors for N-glycosylation (alg2, alg3) 
are  not deficient  in the biosynthesis  of GPI anchors  (8), 
nor do  they accumulate  any abnormal  [2-3H]Ins-labeled 
lipids  (data not shown). Nevertheless,  we wanted  to rule 
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Gaslp. 3  x  outcrossed strains were grown to mid-log phase at 
24°C, and were then further incubated for 1 h  at 24°C or 37°C. 
Proteins were extracted, separated in SDS-PAGE, and blotted. 
Western blotting was carried out with rabbit anti-Gaslp followed 
by sheep anti-rabbit-IgG/peroxidase, and  bands were  revealed 
by chemiluminescence. 
out that the accumulation of abnormal GPI intermediates 
in gpi mutants was an indirect consequence of more gen- 
eral perturbations of the  ER  and the  secretion pathway. 
Since  perturbations  of this  kind  very  often  compromise 
the N-glycosylation and/or the elongation of N-glycans, we 
chose  to  monitor  the  N-glycosylation of  invertase.  The 
electrophoretic mobility of secretory invertase  in  native 
gels is a  good indicator of the status of N-glycans on this 
glycoprotein (1, 2). Native gel electrophoresis showed that 
invertase of gpi9 is underglycosylated to the  same extent 
as the invertase retained in the ER of secl8 cells, that in- 
vertase of gpi4 and gpi6 is partially underglycosylated, and 
that the other gpi mutants glycosylated invertase normally 
(Fig. 11). This suggests that gpi4, gpi6, and gpi9 contain a 
pleiotropic mutation affecting the GPI biosynthesis path- 
way,  as  well as  N-glycosylation. It  should  be  noted  that 
Figure 10.  Kinetics of export of Gaslp out of the ER. W303 cells 
or 3  ×  outcrossed mutant  cells were  grown  to  mid-log phase, 
were preincubated for 60 min at 37°C, and labeled for 10 min with 
[35S]methionine  and [35S]cysteine, and then chased for 0, 5, 10, 30, 
or 60 rain with cold Met and Cys at 37°C as indicated. Gaslp was 
immunoprecipitated and analyzed by SDS-PAGE. 
Figure 11.  N-glycosylation of invertase by gpi mutants. 3  ×  out- 
crossed mutant strains were grown to mid-log phase, and were 
preincubated at 24°C or 37°C for 60 rain. Invertase secretion was 
induced (+) by a further 60 rain incubation in glucose-deprived 
medium at the same temperatures. Alternatively, cells were con- 
trol incubated  (-)  in  medium containing 5%  glucose at 24°C. 
Cells were broken, the cell sap was subjected to electrophoresis 
in a nondenaturing gel system, and invertase was detected by ad- 
dition of a chromogenic substrate. 
these  mutants  accumulate  the  same  GPI  intermediate 
(GlcN-acylPI) as pmi40, sec53, sec59, and dpml,  all mu- 
tants deficient in the biosynthesis or activation of mannose 
(9, 55, 70). The accumulation of the abnormal lipid ofgpi4, 
gpi5, gpi6, and gpi9 mutants  persists even  if mannose  is 
added  to  the  culture  medium  (not  shown).  Thus,  gpi4, 
gpi6, and gpi9 may be further genes required for the acti- 
vation of mannose. 
Gpi Mutants Are Hypersensitive  to Calcofluor  White 
and Hygromycin B 
Sequence  analysis of several cell wall proteins reveals the 
presence of COOH-terminal hydrophobic sequences that 
may direct the attachment of a  GPI anchor  (72),  and for 
certain  proteins,  the  GPI  anchor  represents  a  necessary 
and sufficient signal allowing them to get targeted and in- 
tegrated into the cell wall (69, 80). These findings led us to 
probe the intactness of the cell wails of gpi mutants with 
calcofluor white (CFW) (64). As shown in Table II, wild- 
type cells are not inhibited by 1.5 mg/ml of CFW, whereas 
all mutants  that  are  not  ts  for  growth  in  the  absence  of 
CFW are inhibited by the dye at 37°C.  On the other hand, 
five mutants (gpi4, gpi7-2, gpi7-4, gpi8, and gpi9) are not 
able  to  grow in  high  concentrations  of CFW  already at 
24°C, indicating that their defect can be made apparent al- 
ready at 24°C. 
An increased fragility of the cell wall at 37°C was also in- 
dicated by the fact that several mutants did not grow in the 
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CFWconcentration 
mg/ml 
Strain  0  0.5  1  1.5 
W303  24°C  +++  +++  +++  +++ 
37°C  +++  +++  +++  +++ 
gpi4-1  24°C  +  +  +  +  +  +  +  + 
37°C  .... 
gpi5-1  24°C  +++  +++  +++  +++ 
37°C  +  +  +  -  _ 
gpi6-1  24°C  +++  +++  +++  +++ 
37°C  .... 
839  24°C  +  +  +  +  +  - 
37°C  +  +  -  _  _ 
gpi7-1  24°C  +  +  +  +  +  +  +  +  +  +  +  + 
37°C  +  +  +  -  _ 
gpi7-2  24°C  +  +  +  +  +  +  +  + 
37°C  +  +  -  _  _ 
gpi7-3  24°C  +++  +++  +++  +++ 
37°C  +++  +++  ++  + 
gpi7-4  24°C  +  +  +  +  +  +  +  +  +  +  + 
37°C  +  +  +  -  _ 
gpi8-1  24°C  +  +  +  +  +  +  +  - 
37°C  +  -  _  _ 
gpi9-1  24°C  +++  +++  +++  ++ 
37°C  .... 
Mutant cells were plated out on YPD  agar plates containing 0, 0.5,  1, or  1.5 mg/mt of 
CFW.  Growth at 24  ° or 37°C was monitored after 2 d  of incubation.  Size of emerging 
clones was rated  +  +  +, normal;  +  +, small; +,  very small; and -,  no colonies. 
presence of 50 or 100 IxM hygromycin at 37°C, whereas most 
mutants grew normally in hygromycin at 24°C (Table II) (3). 
Mnn9, a mutant deficient in N-glycan elongation, has a 
fragile cell wall (1), is hypersensitive to CFW (64), and has 
also been reported to have an increased resistance to van- 
adate (3). Therefore, we wanted to verify the vanadate re- 
sistance of gpi mutants. W303 and X2180 cells were resis- 
tant to vanadate up to a concentration of 5 mM. None of 
the  mutants  had  a  higher  resistance  if tested  at  24°C  or 
37°C (Table I). To the contrary, several mutants exhibited 
a reduced colony size when plated at 3 or 5 mM vanadate. 
In  three  strains,  growth  at  37°C  was  influenced  by  the 
Ca + + content of the medium. Gpi5 and 839 almost ceased 
to grow at 50 mM Ca ++, whereas gpi4 was Ca+ +-requiring, 
i.e., it grew to normally sized colonies at 37°C if plated on 
50 mM Ca ++. 
Discussion 
We have developed  a  new approach for the  selection  of 
GPI-anchoring  mutants  in  yeast.  The  procedure  selects 
cells that do not express a GPI protein at the cell surface, 
and follows the same strategy as was used to isolate mam- 
malian GPI-anchoring mutants (28). Since GPI anchoring 
has been claimed to be a vital process for yeast cells, it was 
necessary  to  select  for  temperature-sensitive  mutants. 
~-Agglutinin,  although minor among the numerous  GPI- 
anchored proteins, represents an ideally suited target anti- 
gen for immunoselection. It can be induced after a temper- 
ature shift, and it becomes detectable on the outside of the 
cell wall,  whereas  other  GPI proteins  such  as  Gaslp  re- 
main  anchored  in  the  plasma  membrane,  and  cannot  be 
detected by antibodies  on intact  cells.  Since the negative 
immunoselection enriched not only for gpi mutants but, a 
priori, also selected for mutants in signal transduction via 
the a-factor receptor, transcription,  translation, transloca- 
tion, secretion, and cell-wall integration of a-agglutinin, it 
was necessary to perform additional screens. By eliminat- 
ing mutants unable to induce and secrete acid phosphatase 
at  37°C,  mutants  deficient  in  transcription,  translation, 
translocation,  and  secretion  are  removed,  and  theoreti- 
cally one is left with mutants deficient in GPI anchoring, 
a-factor receptor signaling, and cell-wall integration. Among 
those, our screen detected gpi mutants at a frequency of 
1:70, and we have not tested whether the other mutants re- 
ally are deficient in signaling or cell-wall integration.  It is 
somewhat difficult to estimate  the efficiency of our selec- 
tion procedure. When screening for colonies that fail to in- 
corporate  [2-3H]Ins into proteins,  Leidich et al.  (33)  iso- 
lated  five  mutants  from  25,000  colonies  tested,  but  it 
remains uncertain if any of our mutants would have scored 
in their screen, since none of our mutants seems to be defi- 
cient in [2-3H]Ins incorporation into proteins to the same 
extent  as the mutants  isolated by Leidich et  al.  (33).  On 
the other hand,  it is quite  conceivable that our screening 
procedure selected for leaky mutants, since a mutant that 
rapidly dies at 37°C would probably not have scored as a 
secretor in the 2-d plate assay for secretion  of acid phos- 
phatase. Yet, we believe that GPI anchoring is affected in 
all of our mutants, since all but the gpi9 mutant accumu- 
late a well-defined GPI lipid intermediate,  suggesting that 
one specific step of the pathway has become rate limiting 
in each mutant.  Such defects are compatible with the fact 
that all of the mutants  are recessive,  and that among the 
mutants that have a  growth defect at 37°C, the ts growth 
phenotype cosegregates with  the  accumulation of an ab- 
normal lipid.  By testing a  large panel  of known mutants, 
we  also  could  exclude  that  the  accumulation  of specific 
GPI lipids  occurred  as  an  indirect  consequence  of some 
other perturbation of the secretory pathway; neither secre- 
tion mutants (secl to sec 23) (16, 52, 61) nor ER or Golgi- 
retention mutants (erdl, pmrl, anpl, vanl) (6, 22, 66), nor 
mutants  in N-glycosylation (alg2, alg3)  (27), nor mutants 
in N- or O-glycan elongation (mnnl, mnn2, mnn3, mnn5, 
mnn9, mntl) (1, 23), nor in protein synthesis (prtl-1) accu- 
mulated any abnormal [2-3H]Ins-labeled lipids (Sipos, G., 
and M. Benghezal, unpublished data). In fact, the only gly- 
cosylation mutants  that  accumulate  abnormal  GPI inter- 
mediates  are some mutants  with defects in mannose me- 
tabolism  (sec53,  sec59,  dpml,  pmi40)  and  some  of  our 
mutants  which accumulate  GlcN-acylPI. It is noteworthy 
that none of the 800 isolates tested exhibited any defect in 
the biosynthesis of PI, inositolphosphoceramides, manno- 
sylinositolphosphoceramide,  or  inositolphospho-manno- 
sylinositolphosphoceramide  (61, 71), a finding that argues 
that our selection procedure enriched for GPI mutants, or 
else selected against defects in the biosynthesis of these phos- 
phoinositides. 
What are the steps which are blocked in the various mu- 
tants?  Several  mutants  (gpi4-gpi6,  gpi9)  accumulate  a 
GlcN-acylinositol-lipid intermediate,  and therefore  might 
have a  defect in the al,4-mannosyltransferase  adding the 
first mannose of the GPI core structure  or in the genera- 
tion  of dolicholphosphomannose  required  for this  trans- 
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GPI biosynthesis are compromised in some of these mu- 
tants, the defect may well concern biosynthesis and trans- 
port of dolicholphosphomannose, rather than biosynthesis 
of GDP-mannose,  since  dolicholphosphomannose  seems 
to be required for both of these processes. In fact, dpml, a 
ts mutant in dolicholphosphomannose-synthase, has been 
shown to make (55) and to secrete (Benghezal, M., unpub- 
lished results) a severely underglycosylated invertase. This 
suggests  that  Ochlp  (50,  51)  or  subsequent  elongating 
Golgi  mannosyltransferases  depend  on  the  presence  of 
some  dolicholphosphomannose-derived  core  mannoses. 
Hence,  the  presence  of some  invertase  with  slightly  or 
drastically  increased  mobility in gpi4, gpi6,  and gpi9  at 
37°C  (Fig.  11)  might  be  indicative  of some  difficulty in 
making  dolicholphosphomannose.  Isolate  839  and  gpi7 
might be deficient in the al,2-mannosyltransferase adding 
the third mannose and the phosphoethanolamine group of 
the GPI core structure, respectively. 839 and gpi7 might be 
in genes homologous to the mammalian PIG-B and PIG-F 
(29, 31). Gpi8 might be deficient in the hypothetical trans- 
amidase that attaches CP's to GPI proteins or in a flippase 
that transfers CP's from the cytosolic to the luminal side of 
the ER (76, 77). At the moment, direct assays to measure 
these activities in microsomes have yet to be developed. 
Recently, gaal,  a  ts mutant with  a  phenotype similar to 
gpi8,  has  been  described  (20).  We  find  that  GPI8 and 
GAA1 are different genes since gpi8 and gaal mutants are 
complementing each other and are synthetic lethal when 
combined in a  single haploid strain.  Also, transfection of 
the GAA1 gene on a  multicopy vector does not cure the 
defects of gpi8 cells (not shown). Although not all mutants 
are ts for growth, cloning of the various gpi genes should 
be  aided  by the  fact  that  all  mutants  are  defective  for 
growth on CFW at 37°C. 
Some mutants accumulate severely reduced amounts of 
[2-3H]Ins-labeled  proteins,  but  don't  accumulate  large 
amounts  of abnormal lipids,  whereas  others  accumulate 
large amounts of abnormal lipids, but are less severely af- 
fected in the incorporation of [2-3H]Ins into proteins. Mu- 
tants of both types can even be found among the various 
alleles of a single complementation class, gpi7. To explain 
this paradox, several possibilities might be considered: (a) 
It should be kept in mind that our pulse-labeling protocol 
does not label proteins and lipids to equilibrium, and that 
the observed accumulation of abnormal lipids is the result 
of both,  the  rate  of biosynthesis  as  well  as  the  rate  of 
breakdown. Also, the rate of lipid accumulation of abnor- 
mal lipids  may have been  underestimated  in  mutants in 
which the decay of the mutated enzyme activity at 37°C is 
slow. (b) The same caveats make it impossible to take the 
reduction in [2-3H]Ins labeling of proteins as a measure of 
the reduction of GPI protein biosynthesis. In fact, the half- 
life of label on many GPI proteins is short (9), possibly be- 
cause  the  phosphoinositide  is  lost  from proteins  getting 
incorporated  into  the cell wall  (35),  or because the lipid 
moiety of some GPI proteins are cleaved off at the plasma 
membrane and the proteins are lost into the culture me- 
dium (49). Thus, even in the presence of a significant re- 
duction  of incorporation  of  [2-3H]Ins into  proteins,  the 
amount  of labeled protein  accumulated  during  the  1.5-h 
labeling period may appear normal, if the mutation results 
in  a  slowing down  of vesicular traffic, and  consequently 
the pool size of labeled proteins in the secretory pathway 
is increased. (c) Recent data from Leishmania  major sug- 
gests that GPI's might be synthesized on both sides of the 
ER  membrane  by  two  separate  biosynthetic  pathways 
(44).  If this were the  case in yeast, it also might explain 
why some of our mutants accumulate high amounts of GPI 
lipids but are still able to add GPI anchors to proteins. (d) 
Mutations  that increase the Michaelis constant  (Kin) of a 
given biosynthetic enzyme for its lipid substrate but don't 
alter its maximum velocity are expected to cause a  rela- 
tively major increase of an abnormal GPI intermediate but 
to have less influence on the rate of GPI anchor biosynthe- 
sis. (e) GPI's might be synthesized by a multienzyme com- 
plex  forming  an  assembly  line  in  which  substrates  are 
transferred from one enzyme to the next without having to 
diffuse freely in the  membrane. In this  case, a  mutation 
that renders a given enzyme of the assembly line rate limit- 
ing might lead to a significant reduction of GPI biosynthesis 
without causing the accumulation of an abnormal lipid, as 
long as the GPI intermediates proximal to the blocked en- 
zyme cannot leave the assembly line. On the other hand, 
mutations affecting the interaction of enzymes of the mul- 
tienzyme complex might disrupt the complex and lead to 
the  accumulation  of  abnormal  lipids  that  now  have  to 
reach the following enzyme by diffusion. (f) Mutations might 
also render enzymes insensitive to some negative feedback 
control, which might coordinate the amount of GPI biosyn- 
thesis with the rate of GPI protein synthesis. 
The increased sensitivity of gpi mutants to CFW and hy- 
gromycin B  suggests that  GPI-anchored proteins  are re- 
quired for the integrity of the yeast cell wall. The require- 
ment of GPI anchoring for cell-wall integrity has also been 
documented recently by the group of Frans Klis. Deletion 
of Gaslp results in CFW hypersensitivity (63) and cwh6, a 
CFW-hypersensitive mutant, has a defect in the yeast ho- 
mologue of PIG-A, a gene required for the first step of GPI 
biosynthesis, namely the addition of GlcNAc onto PI (78). 
It  appears  that  our  mutant  isolation  screen  is  by  no 
means exhaustive, since many mutants were only obtained 
once. In addition, several intermediates of the GPI pathway 
such as GlcNAc-PI, GlcN-PI, and GlcN-acylinositol-P-lipid 
would not have been detected since they are expected to 
comigrate on TLC with PI and inositolphosphoceramides. 
We  currently  use  slight  modifications  of  this  screening 
protocol in trying to obtain additional gpi mutants. 
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